Challenges in developing endpoints for type 1 diabetes intervention studies

Simona CERNEA; Itamar RAZ; R. David G LESLIE; Jay S SKYLER; Jerry P PALMER; Kevan C HEROLD; Boaz HIRSHBERG; Bart O ROEP; Desmond A SCHATZ; G. Alexander FLEMING; Paolo POZZILLI; Randie LITTLE; Nanette C SCHLOOT

doi:10.1002/dmrr.1002

Journal article

Challenges in developing endpoints for type 1 diabetes intervention studies

Simona CERNEA, Itamar RAZ, R. David G LESLIE, Jay S SKYLER, Jerry P PALMER, Kevan C HEROLD, Boaz HIRSHBERG, Bart O ROEP, Desmond A SCHATZ, G. Alexander FLEMING, …

Diabetes/metabolism research and reviews, Vol.25(8), pp.694-704

2009

DOI: https://doi.org/10.1002/dmrr.1002

PMID: 19771545

Abstract

Fundamental and applied biological sciences. Psychology

Diabetes. Impaired glucose tolerance

Vertebrates: endocrinology

Biological and medical sciences

Endocrinopathies

Etiopathogenesis. Screening. Investigations. Target tissue resistance

Medical sciences

Endocrine pancreas. Apud cells (diseases)

Metrics

15 Record Views

18 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Industry collaboration; Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.26 Diabetes; 1.26.1016 Type 1 Diabetes
Web Of Science research areas: Endocrinology & Metabolism
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Challenges in developing endpoints for type 1 diabetes intervention studies
Creators: Simona CERNEA - Department of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy
Itamar RAZ - Diabetes Center, Hadassah-Hebrew University Medical School, Jerusalem, Israel
R. David G LESLIE - Centre for Diabetes and Metabolic Medicine, Institute of Cell and Molecular Science, London, United Kingdom
Jay S SKYLER - Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL, United States
Jerry P PALMER - Department of Medicine, University of Washington, Seattle, WA, United States
Kevan C HEROLD - Department of Immunobiology, Yale University School of Medicine, New Haven, CT, United States
Boaz HIRSHBERG - Clinical Research, AstraZeneca LLP, Wilmington, DE, United States
Bart O ROEP - Department of Immunohaematology and Blood Transfusion, Leiden University Medical Center, Leiden, Netherlands
Desmond A SCHATZ - Department of Pediatrics, University of Florida, Gainesville, FL, United States
G. Alexander FLEMING - Kinexum LLC, Harpers Ferry, WV, United States
Paolo POZZILLI - Department of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy
Randie LITTLE - Department of Pathology and Anatomical Sciences, University of Missouri School of Medicine, Columbia, MO, United States
Nanette C SCHLOOT - German Diabetes Center, Institute for Clinical Diabetology, Leibniz-Center for Diabetes Research at the Heinrich-Heine-University, Duesseldorf, Germany
Publication Details: Diabetes/metabolism research and reviews, Vol.25(8), pp.694-704
Publisher: Wiley; Chichester
Academic Unit: Miller School of Medicine; Diabetes Research Institute (DRI)
Language: English
Resource Type: Journal article
PMID: 19771545
Record Identifier: 991031560043902976